U.S. federal trademark · Serial No. 99264992
Pharmaceuticals, namely, proteasome inhibitors; Human pharmaceuticals for use in the treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.